Jorge Á. R.
- Country
- Spain
- Department
- Cardiology
Research Overview
- Efficacy and Safety Evaluation of Sotagliflozin in Patients with Symptomatic Obstructive and Non-obstructive Hypertrophic Cardiomyopathy
- A Phase 2b/3, Adaptive, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Danicamtiv in Participants with Symptomatic Genetic and Familial Dilated Cardiomyopathy (KINSHIP-DCM).
Data & Insights
Has run more than one trial at 9 of 88 partner sites.
Specializations
Cardiovascular Medicine
This investigator specializes in the study of hypertrophic cardiomyopathy (HCM), focusing on both obstructive and non-obstructive variants of this cardiac condition.
- Non-obstructive Hypertrophic Cardiomyopathy
- Obstructive Hypertrophic Cardiomyopathy
The investigator explores innovative therapeutic approaches for managing cardiac symptoms and improving functional capacity in patients with HCM.
Clinical Therapeutics
The investigator's work centers on evaluating novel treatments for symptomatic cardiac conditions, with particular attention to therapeutic interventions that may enhance patient quality of life.
- Symptom Management
- Functional Limitation Assessment
Their research encompasses the evaluation of therapeutic agents for improving cardiovascular symptoms and functional outcomes.
Patient Care Focus
This specialist concentrates on addressing cardiac-related symptoms and their impact on daily living in patients with structural heart conditions.
- Symptom Assessment
- Functional Capacity Evaluation
The investigator's work aims to understand treatment effects on patient symptoms and physical limitations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.